THOMAS, XAVIER,CAPRASSE, VIRGINIE,JOFFRE, ERIC JUDE,KOLLAR, CSILLA,GANTNER, DAVID CLAYTON,RAUL, VICTOR A.
申请号：
EP07795214
公开号：
EP2019678A4
申请日:
2007.05.23
申请国别(地区):
EP
年份:
2012
代理人:
摘要：
The invention provides: a cross-linkable therapeutic composition comprising a) a saccharide-siloxane copolymer； b) a crosslinking agent； c) one or more active/inactive ingredients； and d) optionally, a solvent, or solvent mixture, wherein the saccharide-siloxane copolymer has the following formula: R2aR1(3-a)SiO&mdash；[(SiR2R1O)m-(SiR12O)n]y-SiR1(3-a)R2a that is further formulaically defined and wherein the saccharide-siloxane copolymer is a reaction product of a functionalized organosiloxane polymer and at least one hydroxy-functional saccharide such that the organosiloxane component is covalently linked via a linking group to the saccharide component； films； and methods related thereto. The composition has therapeutic properties. The invention also provides articles of manufacture including topical and transdermal agent delivery patches comprising the novel film-forming composition and/or films.
